Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABX464 PK/PD in HIV
NCT02990325Phase 2Completed
- Sponsor
- Abivax
- Start
- Mar 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of obefazimod in human immunodeficiency virus infection (HIV), sponsored by Abivax. Started Mar 2017; status: completed.
02
Drugs
obefazimod
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02990325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02990325.